[Hyperuricemia due to hypoxanthine-guanine-phosphoribosyltransferase deficiency].
D000328:Adult; D000493:Allopurinol / Q000009:adverse effects / Q000627:therapeutic use*; D000740:Anemia / Q000209:etiology; D001168:Arthritis / Q000209:etiology; D001572:Benzofurans / Q000627:therapeutic use; D006073:Gout / Q000188:drug therapy / Q000209:etiology / Q000235:genetics*; D006801:Humans; D006949:Hyperlipidemias / Q000209:etiology; D007037:Hypothyroidism / Q000139:chemically induced; D007042:Hypoxanthines / Q000378:metabolism*; D007669:Kidney Calculi / Q000209:etiology; D008297:Male; D008661:Metabolism, Inborn Errors / Q000150:complications*; D010375:Pedigree; D010430:Pentosyltransferases / Q000378:metabolism*; D014527:Uric Acid / Q000097:blood*; D014528:Uricosuric Agents / Q000627:therapeutic use
D001572:Benzofurans; D007042:Hypoxanthines; D014528:Uricosuric Agents; D014527:Uric Acid; D000493:Allopurinol; D010430:Pentosyltransferases
Hyperuricémie par déficit en hypoxanthine-guanine-phosphoribosyltransférase